United States Large Volume Parenteral (LVP) Market Offers Customizable IV Fluid and Sterile Drug Delivery Systems

DataM Intelligence has published a new research report on "Large Volume Parenteral Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/large-volume-parenteral-market?kb

Latest M & A

• LTS Lohmann acquires Renaissance Lakewood, expanding sterile dosage and parenteral CDMO capabilities in the U.S. (October 2025) - reinforcing sterile fill-finish footprint critical for parenteral products.

• Thermo Fisher Scientific completes acquisition of Sanofi's sterile manufacturing site in Ridgefield, NJ, boosting capacity for sterile and parenteral drug production.

• Halo Pharma sterile CDMO business ramps up as a dedicated contract manufacturing organization, reflecting consolidation and specialization in sterile drug product services

Key Players:

B. Braun Melsungen AG, Baxter Healthcare Corporation, Fresenius Kabi AG, Pfizer, Inc., BML Parenteral Drugs, Emcure Pharmaceuticals Ltd, Otsuka Pharmaceutical Factory, Inc., Beximco Pharma, China Resources Pharmaceutical GroupCo., Ltd. and Ozon Pharmaceuticals.

Key Development:

Jan 2026 Highlights:

• New biocompatible container technologies introduced to enhance drug stability.

• Expansion of LVP manufacturing facilities announced in North America to meet rising demand.

• Adoption of advanced automation in LVP filling lines to improve production efficiency.

Dec 2025 Highlights:

• Strategic partnerships formed between pharma companies and contract manufacturers for LVPs.

• Regulatory bodies update guidelines on sterilization standards for large volume injectables.

• Growth in demand for preservative-free LVP formulations observed in emerging markets.

Nov 2025 Highlights:

• Innovative delivery systems for LVPs gain traction, focusing on patient convenience.

• Investments in cold chain logistics to support temperature-sensitive LVPs increased.

• Key players announced pipeline expansions targeting biosimilar LVP products.

Growth Forecast Projected:

The Global Large Volume Parenteral Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Large Volume Parenteral Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=large-volume-parenteral-market?kb

Key Segments:

By Volume: 250 ml - 500 ml, 100 ml - 250 ml, 500 ml - 1000 ml, 1000 ml - 2000 ml

By Application: Nutritious Injections, Vitamin B12, Isolyte M in Dextrose, Fluid Balance Injections, Hypertonic Saline (3% and 5% Sodium Chloride Injection, 5% Dextrose and Electrolyte, Therapeutic Injection

By Type of Packaging: Bottles, Bags

Regional Analysis for Market:

United States: Recent Industry Developments
✅ January 2026: Baxter International expanded its LVP manufacturing facility to support increased demand for sterile injectable solutions.

✅ December 2025: Fresenius Kabi launched a new range of preservative-free LVPs tailored for critical care settings.

✅ November 2025: FDA updated guidelines to streamline approval processes for biosimilar LVP products.

Japan: Recent Industry Developments
✅ January 2026: Terumo Corporation invested in state-of-the-art aseptic filling lines for LVPs to meet growing domestic needs.

✅ December 2025: Local pharma companies increased focus on high-quality, low-volume LVP formulations for niche therapies.

✅ November 2025: Regulatory collaboration between Japan's PMDA and manufacturers accelerated LVP product approvals.

Middle East: Recent Industry Developments
✅ January 2026: Gulf Pharmaceutical Industries (Julphar) announced a new sterile LVP production facility to serve the regional market.

✅ December 2025: Governments initiated public-private partnerships to improve injectable drug accessibility across healthcare systems.

✅ November 2025: Rising demand for oncology and critical care LVPs led to increased imports and local production initiatives.

Europe: Recent Industry Developments
✅ January 2026: Novartis expanded LVP manufacturing capabilities in Switzerland, focusing on oncology injectable therapies.

✅ December 2025: EMA introduced enhanced pharmacovigilance requirements for LVP products to ensure patient safety.

✅ November 2025: European manufacturers invested in green manufacturing technologies to reduce environmental impact of LVP production.

Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/large-volume-parenteral-market?kb

FAQ

Q: How rapidly will the Market expand?

A: The Large Volume Parenteral market is projected to grow at a CAGR of 3.1% between 2024 and 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Contact Us For Custom Research: https://www.datamintelligence.com/custom-research?kb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.